<DOC>
	<DOC>NCT01577069</DOC>
	<brief_summary>The purpose of the study is to 1- detect and quantify HCV-PI resistant mutants with ultra-deep pyrosequencing (UDPS) technology, 2 - detect SNPs in P-glyocoprotein and CYP3A genes, in HCV mono-infected patients under/after Telaprevir treatment.</brief_summary>
	<brief_title>Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>HCV monoinfected subjects Age &gt; 18 years HBV coinfection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Direct Antiviral agent (DAA)</keyword>
	<keyword>Ultra-deep pyrosequencing</keyword>
	<keyword>Single polynucleotide polymorphisms</keyword>
	<keyword>Treatment-resistant mutants</keyword>
	<keyword>Hepatitis C Virus Protease Inhibitor</keyword>
</DOC>